BioEnergy Development Overview
Latest ROE for BioEnergy Development: 615.61% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow615.61%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CNER is 615.61%. That is above the sector sector average of 11.75%. Investors often review this figure alongside BioEnergy Development's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CNER currently prints 615.61% for ROE, while the sector average sits near 11.75%. That is roughly 5137.4% above the sector mean. Large gaps often invite a closer look at BioEnergy Development's growth, margins, and balance sheet.
Return on Equity shows how effectively BioEnergy Development converts resources into returns. At 615.61%, CNER may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CNER's ROE (615.61%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
